The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their ...

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

Trials are used to test potential medicines, treatments or procedures. The National Institutes for Health define a clinical ...

The trial will be a collaborative effort between the company, the Norwegian Cancer Society, and Cancer Research UK.

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule MEK 1/2 inhibitor. The platform analyzed cellular models of APC gene loss-the root cause of FAP-to identify compounds ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...